BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16439711)

  • 1. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
    Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.
    Mabuchi H; Nohara A; Inazu A
    Mol Cells; 2014 Nov; 37(11):777-84. PubMed ID: 25410905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein and its inhibition.
    Weber O; Bischoff H; Schmeck C; Böttcher MF
    Cell Mol Life Sci; 2010 Sep; 67(18):3139-49. PubMed ID: 20556633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CETP inhibitors and cardiovascular disease: Time to think again.
    Miller NE
    F1000Res; 2014; 3():124. PubMed ID: 25187879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CETP inhibition enhances monocyte activation and bacterial clearance and reduces streptococcus pneumonia-associated mortality in mice.
    Deng H; Liang WY; Chen LQ; Yuen TH; Sahin B; Vasilescu DM; Trinder M; Walley K; Rensen PCN; Boyd JH; Brunham LR
    JCI Insight; 2024 Apr; 9(8):. PubMed ID: 38646937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL as a Treatment Target: Should We Abandon This Idea?
    Begue F; Apalama ML; Lambert G; Meilhac O
    Curr Atheroscler Rep; 2023 Dec; 25(12):1093-1099. PubMed ID: 38051472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cholesteryl Ester Transfer Protein Contributes to the Protection of Ginsenoside Re Against Isoproterenol-Induced Cardiac Hypertrophy.
    Qiu Y; Xie M; Ding X; Zhang H; Li H; Wang H; Li T; Dong W; Jiang F; Tang X
    Cureus; 2024 May; 16(5):e59942. PubMed ID: 38854305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel cholesteryl ester transfer protein (CETP) inhibitors by a multi-stage virtual screening.
    Liu Y; Deng L; Ding F; Wang Q; Zhang S; Mi N; Zhang W; Zeng B; Tong H; Wu L
    BMC Chem; 2024 May; 18(1):95. PubMed ID: 38702788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein knock-down in conjunction with a cholesterol-depleting agent decreases tamoxifen resistance in breast cancer cells.
    Gu L; Pillay RP; Aronson R; Kaur M
    IUBMB Life; 2024 May; ():. PubMed ID: 38733508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol will become a new model for treating cerebral infarction with a high risk of hemorrhage: A narrative review.
    Lang L; Zhang J; Zheng D; Gao H
    Brain Circ; 2023; 9(4):222-227. PubMed ID: 38284116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Diterpenes from Cultures of the Fungus Engleromyces goetzii and Their CETP Inhibitory Activity.
    Wang Y; Zhang L; Wang F; Li ZH; Dong ZJ; Liu JK
    Nat Prod Bioprospect; 2015 Apr; 5(2):69-75. PubMed ID: 25850378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CETP inhibition in the REVEAL trial: could we aim higher?
    Sahebkar A; Mikhailidis DP; Banach M
    Arch Med Sci; 2020; 16(5):1229-1230. PubMed ID: 32864013
    [No Abstract]   [Full Text] [Related]  

  • 13. Obicetrapib: There is still Life in the CETP Inhibitor!
    Ogura M
    J Atheroscler Thromb; 2024 Jun; ():. PubMed ID: 38880604
    [No Abstract]   [Full Text] [Related]  

  • 14. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
    Kastelein JJP; Hsieh A; Dicklin MR; Ditmarsch M; Davidson MH
    Curr Atheroscler Rep; 2024 Feb; 26(2):35-44. PubMed ID: 38133847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients.
    Chang CK; Chiang EI; Chang KH; Tang KT; Chen PK; Yip HT; Chen CH; Chen DY
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
    Xue H; Zhang M; Liu J; Wang J; Ren G
    Curr Atheroscler Rep; 2023 Apr; 25(4):155-166. PubMed ID: 36881278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both full length-cholesteryl ester transfer protein and exon 9-deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes.
    Liu Y; Mihna D; Izem L; Morton RE
    Lipids; 2022 Jan; 57(1):69-79. PubMed ID: 34866179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study.
    Colombo GI; Bianconi V; Bonomi A; Simonelli S; Amato M; Frigerio B; Ravani A; Vitali C; Sansaro D; Coggi D; Mannarino MR; Savonen KP; Kurl S; Gigante B; Smit AJ; Giral P; Tremoli E; Calabresi L; Veglia F; Pirro M; Baldassarre D; On Behalf Of The Improve Study Group
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33799675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?
    Ren K; Xu XD; Yu XH; Li MQ; Shi MW; Liu QX; Jiang T; Zheng XL; Yin K; Zhao GJ
    Aging (Albany NY); 2020 Nov; 12(21):22335-22349. PubMed ID: 33154191
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.